Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure DAPAgliflozin and Effect on Cardiovascular Events in ACuTe Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
Location: CPMC (San Francisco)
Please contact: Milena Ferreira ferreiml@sutterhealth.org about study DAPA
Principal Investigator
Co-Investigator(s)
Related Studies
Interpretable Deep Learning Model for Longitudinal Electronic Health Record and Applications to Heart Failure Prediction
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator